ACVR1B and pancreatic ductal adenocarcinoma: Interestingly, the Activin Signalling Pathway is known to function as both–a tumor-suppressor and a tumor-initiator in cancer (Qiu et al., 2021), although this phenomenon was initially described for ACVR1B in pancreatic ductal adenocarcinoma (PDAC).